| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/13/2004 | US20040092437 Using genetically engineered mammalian plasma protein to prevent and treat transplant rejection, graft-versus-host and autoimmune diseases; side effect reduction and tumor therapy |
| 05/13/2004 | US20040092436 Immunosuppressive imidazole derivatives and their combination preparations with tacrolimus of cyclosporins |
| 05/13/2004 | US20040092435 Treatment of ocular disease |
| 05/13/2004 | US20040092434 Oligopeptides; antitumor agents, antiinflammatory agents, antiischemic agents, vision defects |
| 05/13/2004 | US20040092433 Use of zwitterionic polysaccharides for the specific modulation of immune processes |
| 05/13/2004 | US20040092432 Cognition activators; central nervous system disorders; administering isolated nucleic acid |
| 05/13/2004 | US20040092431 Therapy for vision defects |
| 05/13/2004 | US20040092430 Antitumor agents; antiinflammatory agents; autoimmune disease |
| 05/13/2004 | US20040092429 Cardiovascular disorders; antiarrhythmia agents; controlling phosphorylation of cells, tissues |
| 05/13/2004 | US20040092428 Oral pharmaceuticals formulation comprising paclitaxel, derivatives and methods of administration thereof |
| 05/13/2004 | US20040092015 Coupling; binding aldehyde compound forming hydrazone compound; lipophilic vector |
| 05/13/2004 | US20040092008 Recombinant AAV vectors for gene therapy of hemophilia A |
| 05/13/2004 | US20040092007 Allelic growth differentiation factor-9b (GDF-9B) for treatment annd prevention of sex disorders; in vitro fertilization; artificial insemination; veterinary medicine |
| 05/13/2004 | US20040091995 Replication defective poxvirus coding granulocyte-monocyte-colony stimulating factor (GM-CSF) for treatment and prevention of neutropenia and tumor disorders; antitumor/antiproliferative agents |
| 05/13/2004 | US20040091993 Comprises peptides associated with rho/rac-interacting citron kinase for identifying modulators for treatment, diagnosis and prevention of cell proliferative disorders |
| 05/13/2004 | US20040091972 Membrane protein for diagnosis, prevention and treatment cell proliferative disorders |
| 05/13/2004 | US20040091968 Recombinant phytases and methods of making and using them |
| 05/13/2004 | US20040091965 Regulation of human adam-ts-like protein |
| 05/13/2004 | US20040091964 Modified proteins, isolated novel peptides,and uses thereof |
| 05/13/2004 | US20040091960 Novel physiologically active peptides and use thereof |
| 05/13/2004 | US20040091956 Biosynthesis using blocked amino acids; deblocking; separation; purification; immunomoderators; multiple sclerosis |
| 05/13/2004 | US20040091942 Measuring concentration of phospho-tau protein in body/brain fluids for detecting alzheimer's, nervous system and brain disorders |
| 05/13/2004 | US20040091928 Comprises nucleotide sequences coding transmembrane receptors for identification of modulator for diagnosis, prevention and treatment of psychological and schizophrenic disorders |
| 05/13/2004 | US20040091919 Antisense modulation of superoxide dismutase 1, soluble expression |
| 05/13/2004 | US20040091918 Methods and kits for synthesis of siRNA expression cassettes |
| 05/13/2004 | US20040091907 GEF-H1b: biomarkers, complexes assays and therapeutic uses thereof |
| 05/13/2004 | US20040091894 Flea gaba receptor subunit nucleic acid molecules, proteins and uses thereof |
| 05/13/2004 | US20040091890 Life sciences business systems and methods |
| 05/13/2004 | US20040091884 For diagnosis of/drugs for inflammatory bowel disease/asthma/ diabetes/arthritis/cirrhosis/skin disorders |
| 05/13/2004 | US20040091878 Zinc finger domain recognition code and uses thereof |
| 05/13/2004 | US20040091871 For diagnosis/treatment/prophylaxis of neuroendocrine disorders; antisense agents; kits |
| 05/13/2004 | US20040091856 DNA sequences from staphylococcus aureus bacteriophage 44AHJD that encode anti-microbial polypeptides |
| 05/13/2004 | US20040091852 Glycoprotein peptide of the human herpesvirus-7 for use in particular in an elisa serologic test |
| 05/13/2004 | US20040091578 Treating a protein containing disulfide bonds withthioredoxin, nicotinamide adenine dinucleotide phosphate- thioredoxin reductase and NADPH or dithiothreitol reacting the protein with physiological disulfide; administering |
| 05/13/2004 | US20040091554 Nutritional supplement containing alpha-glucosidase and alpha-amylase inhibitors |
| 05/13/2004 | US20040091544 Applying a solution of the active pharmaceutical ingredient, e.g. a peptide such as insulin, to form a coating on a particulate substrate which is free of a polysaccharide; permeation promoter coating to control release; capsules |
| 05/13/2004 | US20040091522 Lipid microparticles by cryogenic micronization |
| 05/13/2004 | US20040091514 Applying an aqueous mixture comprising protease, surfactants, detergent builders, for exterminating pests |
| 05/13/2004 | US20040091509 Skin care composition that mediates cell to cell communication |
| 05/13/2004 | US20040091503 Lectin compositions and methods for modulating an immune response to an antigen |
| 05/13/2004 | US20040091501 Immunosuppresor agent derived from morbillivirus |
| 05/13/2004 | US20040091500 Non-naturally occurring mutants from naturally occurring allergens; overall alpha-carbon backbone tertiary structure of the allergens is preserved; use in vaccines; treating allergies; reduced immunoglobulin E (IgE) binding |
| 05/13/2004 | US20040091498 Defensins: use as antiviral agents |
| 05/13/2004 | US20040091493 Active ingredient such as specified plant extract(s) or calcium compound that does not cause any inflammatory, irritation or intolerance reactions; tissue models for drug screening for drugs against skin disorders; dandruff, acne |
| 05/13/2004 | US20040091492 Use in tumor therapy; vaccine adjuvant to enhance cytotoxic T-cell (CTL) response; fusion proteins incorporate onto the surface of Major Histocompatibility Complex I expressing cells to increase CTL response to antigens on the cells |
| 05/13/2004 | US20040091488 Antigenic constructs of major histocompatibility complex class I antigens with specific carrier molecules, the preparation and use thereof |
| 05/13/2004 | US20040091484 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 05/13/2004 | US20040091483 Inhibitor of SNARE effective in preventing cytokinesis in a population of cells; SNARE membrane fusion machinery, syntaxin 2 and endobrevin/VAMP-8; cells become more susceptible to apoptosis; possible use against tumors |
| 05/13/2004 | US20040091481 Method for modulating the binding activity of a novel icam-3 binding receptor on sinusoidal endothelial cells in liver and lymph nodes |
| 05/13/2004 | US20040091479 T-cell epitope of the papillomavirus l1 and e7 protein and use thereof in diagnostics and therapy |
| 05/13/2004 | US20040091477 Immunophilin-binding compound and ginkgolide compound |
| 05/13/2004 | US20040091476 Enhance or suppress T-cell activation and proliferation |
| 05/13/2004 | US20040091473 Metalloproteinase-disintegrin polypeptides and methods of making and use thereof |
| 05/13/2004 | US20040091472 Rationally designed polysaccharide lyases derived from chrondroitinase B |
| 05/13/2004 | US20040091471 Synthetic; higher specific activity than native glycuronidase |
| 05/13/2004 | US20040091470 Use of bacterial phage associated lytic enzymes to prevent food poisoning |
| 05/13/2004 | US20040091469 Novel enzyme having beta-glucosidase activity and use thereof |
| 05/13/2004 | US20040091468 Novel transcriptional mediators of blood vessel development and endothelial differentiation |
| 05/13/2004 | US20040091466 Regulatory protein for nox enzymes |
| 05/13/2004 | US20040091465 Endostatin combined with sucrose octasulfate |
| 05/13/2004 | US20040091464 Isolated stromal cells for use in the treatment of diseases of the central nervous system |
| 05/13/2004 | US20040091457 Compositions and methods for inhibiting viral replication |
| 05/13/2004 | US20040091455 Methods of using and compositions comprising immunomodulatory compounds for treatment and management of macular degeneration |
| 05/13/2004 | US20040091454 Methods of using and compositions comprising selective cytokine inhibitory drugs for treatment and management of macular degeneration |
| 05/13/2004 | US20040091423 Methods for identifying asymptomatic patients who have a likelihood of benefiting from administration of an estrogen activity modulator for risk reduction or therapeutic treatment of breast cancer, methods for reducing risk or |
| 05/13/2004 | US20040091407 Novel process for preparing crystalline particles of a salt of a substance, particularly particles of therapeutically useful or carrier substances of a size suitable for inhalation therapy. |
| 05/13/2004 | US20040089290 Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume |
| 05/13/2004 | DE20220744U1 Mittel zur Hemmung von Lentiviren Means for inhibiting lentiviruses |
| 05/13/2004 | DE10250870A1 Zusammensetzung enthaltend Aktivatoren von IK-Kaliumkanälen und Calcineurin-Antagonisten und deren Verwendung Composition containing activators of IK potassium channels and calcineurin antagonists and their use |
| 05/13/2004 | DE10249860A1 Use of neuroglobin for producing a medicament for treating diseases of retina, or for producing a diagnostic agent for diagnosing diseases of the retina |
| 05/13/2004 | CA2505852A1 Treatment of immunological renal disorders by lymphotoxin pathway inhibitors |
| 05/13/2004 | CA2504228A1 Protozoan rhomboid proteins |
| 05/13/2004 | CA2504205A1 Angiotensin-converting enzyme containing medecine |
| 05/13/2004 | CA2504178A1 Methods and kits for diagnosing tumorigenicity |
| 05/13/2004 | CA2503886A1 Recombinant protein variants |
| 05/13/2004 | CA2503763A1 Compositions and methods for modifying toxic effects of proteinaceous compounds |
| 05/13/2004 | CA2503697A1 Trimeric binding proteins for trimeric cytokines |
| 05/13/2004 | CA2503693A1 Use of cpg oligonucleotides in the treatment of hepatitis c virus infection |
| 05/13/2004 | CA2503670A1 Crystals of insulin analogues and method for the production thereof |
| 05/13/2004 | CA2503634A1 Alpha 1-antichymotrypsin in combination with alpha 1-antitrypsin for the treatment of wounds |
| 05/13/2004 | CA2503624A1 Use of a nitric oxide donor to prevent desensitization of g-protein coupled receptors |
| 05/13/2004 | CA2501180A1 Actriib fusion polypeptides and uses therefor |
| 05/13/2004 | CA2498642A1 Composition for the treatment of infection by flaviviridae viruses |
| 05/13/2004 | CA2498264A1 G protein coupled receptors and uses thereof |
| 05/12/2004 | EP1418428A1 Method to provide natural therapeutic agents with high therapeutic index |
| 05/12/2004 | EP1418236A1 Mammalian chemokines |
| 05/12/2004 | EP1418235A2 Intracellular domain of the her-2/neu protein for prevention or treatment of maligancies |
| 05/12/2004 | EP1418228A1 Macroencapsulated secretory cells |
| 05/12/2004 | EP1418183A1 Cystic fibrosis gene |
| 05/12/2004 | EP1418182A1 Method of preparing peptide fragment having cell death inhibitory activity |
| 05/12/2004 | EP1418179A2 Compositions and methods for detecting and modulating rna activity and gene expression |
| 05/12/2004 | EP1417972A1 Stabilized teriparatide solutions |
| 05/12/2004 | EP1417971A2 Use of an angiogenic factor for the treatment of microvascular angiopathies |
| 05/12/2004 | EP1417353A1 Methods and compositions relating to hpv-associated pre-cancerous and cancerous growths, including cin |
| 05/12/2004 | EP1417351A2 Antisense modulation of apolipoprotein(a) expression |
| 05/12/2004 | EP1417350A2 Antisense modulation of hormone-sensitive lipase expression |
| 05/12/2004 | EP1417342A2 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer |
| 05/12/2004 | EP1417339A2 Antisense modulation of glioma-associated oncogene-2 expression |
| 05/12/2004 | EP1417335A2 Antisense modulation of glioma-associated oncogene-3 expression |
| 05/12/2004 | EP1417328A2 Invasion complex and methods of targeting |